BMC Psychiatry

official impact factor 2.89

Open Access

Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

Paul D Carey*, Bavanisha Vythilingum, Soraya Seedat, Jacqueline E Muller, Michael van Ameringen and Dan J Stein

BMC Psychiatry 2005, 5:5 doi:10.1186/1471-244X-5-5

Accesses  

  • Last 30 days: 61 accesses
  • Last 365 days: 755 accesses
  • All time: 6062 accesses

Cited by

BioMed Central: 1 citation